Skip to main content
. 2017 Dec 19;15(3):2953–2961. doi: 10.3892/ol.2017.7647

Figure 3.

Figure 3.

EZH2 expression status in patients with CRC. (A) EZH2 mRNA expression in patients with CRC. Patients with high EZH2 expression were classified into overexpressed group and those with low expression were into under-expressed group (cut-off value, 0.39). (B) EZH2 protein expression in patients with CRC. (C) Immunohistochemical analysis of EZH2 expression in patients with CRC. Images were captured at ×200 magnification. ***P<0.001. NS, not significant; CRC, colorectal cancer; EZH2, enhancer of zeste homolog 2.